A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments

International Journal for Quality in Health Care

Volumn 23, Issue 2, 2011, Pages 142-150

  Mcintosh, Kylie A ^a,b   Maxwell, David J ^c   Pulver, Lisa K ^d   Horn, Fiona ^e,f   Robertson, Marion B ^b,g   Kaye, Karen I ^c,f   Peterson, Gregory M ^h   Dollman, William B ^i,j   Angelawai, ^f   Tett, Susan E ^d  

^a Statewide Quality Branch   (Australia)

^b Victorian Drug Usage Evaluation Group   (Australia)

^c NSW Therapeutic Advisory Group   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e New South Wales Government   (Australia)

^f National Prescribing Service   (Australia)

^g ROYAL MELBOURNE HOSPITAL   (Australia)

^h UNIVERSITY OF TASMANIA   (Australia)

ⁱ Drug & Alcohol Services South Australia   (Australia)

^j Southern Adelaide Health Service   (Australia)

more..

Author keywords

Community acquired infections; Evidence based; Guideline adherence; Health care; Pneumonia drug therapy ; Quality assurance

Indexed keywords

ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG USE; EMERGENCY WARD; HEALTH CARE QUALITY; HOSPITAL; MEDICAL AUDIT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAL AUDIT; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; SEVERITY OF ILLNESS INDEX;

EID: 79952611084     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzq077     Document Type: Article

References (36)

1. File TM Jr, Garau J, Blasi F et al. Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 2004;125:1888-901.
2. Centers for Disease Control and Prevention, National Center for Health Statistics, Health, United States 2007, table 31. [updated November 2007; cited 16 June 2008]. Available from URL: http://www.cdc.gov/nchs/data/hus/hus07.pdf.
3. Johnson PD, Irving LB, Turnidge JD. Community-acquired pneumonia. Med J Aust 2002;176:341-7.
4. Tsirgiotis E, Ruffin R. Community-acquired pneumonia. A perspective for general practice. Aust Fam Physician 2000;29:639-45.
5. AIHW National Hospital Morbidity Database, Principal diagnosis cubes, 2004-05. [updated 25 March 2008; cited 15 June 2008]. Available from URL: http://www.aihw.gov.au/hospitals/datacubes/datacube_pdx.cfm.
6. Niederman MS, Mandell LA, Anzueto A et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
7. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of communityacquired pneumonia in adults. Thorax 2001(Suppl. 4);56:S1-64.
8. Lim WS, van der Eerden MM, Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58: 377-82.
9. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
10. ERS Task Force Report. Guidelines for management of adult community acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998;11:986-91.
11. Mandell LA, Bartlett JG, Dowell SF et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33.
12. Antibiotic Writing Group. Therapeutic Guidelines: Antibiotic. Version 12. Melbourne: Therapeutic Guidelines Limited, 2003.
13. Arnold FW, LaJoie S, Brock GN et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009;169:1515-24.
14. Dambrava PG, Torres A, Valles X et al. Adherence to guidelines' empirical antibiotic recommendations and communityacquired pneumonia outcome. Eur Respir J 2008;32:892-901.
15. Buising KL, Thursky KA, Black JF et al. Improving antibiotic prescribing for adults with community acquired pneumonia: does a computerised decision support system achieve more than academic detailing alone? A time series analysis. BMC Med Inform Decis Mak 2008;8:35.
16. Doyon S, Perreault M, Marquis C et al. Quantitative evaluation of a clinical intervention aimed at changing prescriber behaviours in response to new guidelines. J Eval Clin Prac 2009;15:1111-7.
17. Frei CR, Attridge RT, Mortensen EM et al. Guidelineconcordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 2010;32:293-9.
18. Weekes LM, Jackson JM, Fitzgerald M et al. National Prescribing Servcie: creating an implementation arm for national medicines policy. Br J Clin Pharmacol 2005;59:112-6.
19. SHPA standards of practice for drug usage evaluation in Australian hospitals. J Pharm Pract Res 2004;34:220-3.
20. Pulver LK, Tett SE. Drug utilization review across jurisdictions-a reality or still a distant dream? Eur J Clin Pharmacol 2006;62:97-106.
21. Australian Institute of Health and Welfare (AIHW) 2004. Australian Hospital Statistics 2003-04. Table A4.3 AIHW cat. No. HSE 37. Canberra: AIHW (Health Services Series no 23). [cited 15 June 2008]. Available from URL: http://www.aihw.gov.au/publications/hse/ahs03-04/Appendix_4.xls.
22. Jamtvedt G, Young JM, Kristoffersen DT et al. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD000259. DOI: 10.1002/14651858.CD000259.pub2. Accessed 13 August 2007.
23. Soumerai S, Avorn J. Improving drug therapy decisions through educational outreach: a randomized controlled trial of academically based detailing. N Eng J Med 1983;308: 1457-63.
24. Soumerai S, Avorn J. Principles of educational outreach (academic detailing) to improve clinical decision making. JAMA 1990;263:549-56.
25. SAS Institute Inc. Cary, NC, USA: SAS Institute Inc., 2006.
26. Maxwell DJ, McIntosh KA, Pulver LK et al. Empiric management of community-acquired pneumonia in Australian emergency departments. Med J Aust 2005;183:520-24.
27. McCabe C, Kirchner C, Zhang H et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia. Arch Int Med 2009;169: 1525-31.
28. Battleman DS, Callahan M, Thaler HD. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Int Med 2002;162:682-8.
29. Dean NC, Bateman KA, Donnelly SM et al. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006;130:794-99.
30. Serisier DJ, Bowler SD. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia. Respirology 2007;12:389-93.
31. Halm EA, Horowitz C, Silver A et al. Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care. Chest 2004;126:100-7.
32. Yealy DM, Auble TE, Stone RA et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 2005;143:881-94.
33. Halm EA, Atlas SJ, Borowsky LH et al. Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Int Med 2000;160: 98-104.
34. Paterson D, Playford E. Should third-generation cephalosporins be the empirical treatment of choice for severe communityacquired pneumonia in adults? Med J Aust 1998;168:344-8.
35. Salkind AR, Cuddy PG, Foxworth JW. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001;285:2498-505.
36. Antibiotic Writing Group. Therapeutic Guidelines: Antibiotic. Version 13. Melbourne: Therapeutic Guidelines Limited, 2006.